Cardiotube Interview: LBCT: Tirzepatide Reduces Subclinical Leaflet Thrombosis And Paravalvular Leak After Transcatheter Aortic Valve Replacement In Obese Patients

Sunday, March 8, 2026

1:30 PM - 1:45 PM EST

Location: Lobby Level - Next to Speaker Ready

Interviewer(s)

Daniel H. Steinberg, MD

Professor of Medicine and Surgery
Medical University of South Carolina
Charleston, South Carolina, United States

Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Interviewee(s)

AM Thirugnanam, MD

Director of Cath lab
Ipcard Cardiac Care center, Hyderabad
Hyderabad, India

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Daniel H. Steinberg, MD: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

AM Thirugnanam, MD: No financial relationships to disclose